Back to News
research

BioHarvest Sciences Inc. (BHST) Q4 2025 Earnings Call Transcript

Seeking Alpha
Loading...
2 min read
0 likes
⚡ Quantum Brief
BioHarvest Sciences reported Q4 2025 earnings with $9.07M revenue, a 24.57% year-over-year increase but $173K below estimates, while EPS of -$0.10 met expectations. CEO Ilan Sobel and CFO Bar Dichter led the March 31, 2026 call, emphasizing growth despite the revenue miss, citing operational expansion and product demand. The company highlighted forward-looking statements under SEC safe harbor rules, warning investors of potential risks outlined in their latest Form 40-F filings. Analysts from Maxim Group, Craig-Hallum, and ROTH Capital participated, probing financial health and strategic plans during the Q&A session. Executives reiterated confidence in long-term scaling, though no specific updates on quantum or biotech breakthroughs were disclosed during the call.
AI Audio Summary
0:00 / 0:00
Click to play
christian-wiediger-c3ZWXOv1Ndc-unsplash.jpg
Quantum News · Media Library

SA Transcripts159.17K FollowersFollow5ShareSaveCommentsQ4: 2026-03-31 Earnings SummaryPlay CallPlay CallEPS of -$0.10 beats by $0.00 | Revenue of $9.07M (24.57% Y/Y) misses by $173.00K BioHarvest Sciences Inc. (BHST) Q4 2025 Earnings Call March 31, 2026 4:30 PM EDT Company Participants Justin MeiklemIlan Sobel - Chief Executive OfficerBar Dichter - Chief Financial OfficerZaki Rakib - Co-Founder, Executive Chairman & President Conference Call Participants Anthony Vendetti - Maxim Group LLC, Research DivisionMatthew Hewitt - Craig-Hallum Capital Group LLC, Research DivisionSean McGowan - ROTH Capital Partners, LLC, Research DivisionSusan Anderson - Canaccord Genuity Corp., Research Division Presentation Operator Hello, everyone. Thank you for joining us, and welcome to the BioHarvest Sciences Fourth Quarter and Year-End 2025 Earnings Call. [Operator Instructions] I will now hand the call over to Justin Meiklem, Head of Investor Relations. Please go ahead.

Justin Meiklem Greetings. With us on the call are Dr. Zaki Rakib, Chairman; Ilan Sobel, Chief Executive Officer; and Bar Dichter, Chief Financial Officer. Before we begin, I'd like to remind you that management will be making projections and forward-looking statements on the call today regarding future events. Any statements that are not historical facts are forward-looking statements. These statements are made pursuant to and within the meaning of the safe harbor provision of the Private Securities Litigation Reform Act of 1995. We encourage you to review BioHarvest Sciences' SEC filings, including the company's most recent Form 40-F, which identify risks and uncertainties that may cause future actual results or events to differ materially. These filings can be found on the company website, as well as the SEC's website at www.sec.gov. Please note that the forward-looking statements made during today's call speak only to the date they are made, and BioHarvest Sciences undertakes no obligation to update them. And with that, I would like to now turn the call over to Ilan Sobel, Chief Executive Officer. Ilan? Ilan SobelChief Executive Officer Thank you. I want to thank

Read Original

Source Information

Source: Seeking Alpha

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.